News Daily News FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients L.A. McKeown August 21, 2024
News Daily News HeartMate 3 Recalled for Risk of Blood Leaks or Air in System L.A. McKeown May 15, 2024
News Daily News HeartMate II and 3 LVADs Recalled Due to Potential for Outflow Graft Obstruction Caitlin E. Cox April 22, 2024
News Conference News THT 2024 Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients Michael O'Riordan March 07, 2024
Presentation THT Abstracts 2024 Does Guideline-Directed Medical Therapy Improve Outcomes in HeartMate 3 Patients? Presenter: Julia Baranowska March 05, 2024
Presentation THT Abstracts 2024 Central and Peripheral Determinants of Exercise with the HeartMate 3TM LVAD Presenter: David Golombeck March 05, 2024
Presentation THT Abstracts 2024 Guideline-Directed Heart Failure Therapy in HeartMate 3 Patients Presenter: Changhee Lee March 05, 2024
Presentation THT 2024 Decathlon: In it for the Long Run - What are the Next Steps with HeartMate 3 LVAD Therapy? Presenter: Jennifer A. Cowger March 05, 2024
Presentation THT 2024 Decade: 10 years and Counting Since the First HeartMate 3 LVAD Implantation - What have we Learned? Presenter: Nir Uriel March 05, 2024
News Daily News HeartMate 3 Use Postapproval Is Soaring—and Equitably, New Numbers Show Yael L. Maxwell January 10, 2024